CRISPR Topical Gene Therapy Duchenne Muscular Dystrophy Sickle Cell Disease Treatment Gene-Editing Treatment Blood Disorders Gene-Editing Tools Bone Marrow Transplant Casgevy Treatment Sickle-Cell Disease Treatment Crispr Gene Editing CRISPR-based Medicine CRISPR/Cas9 Blood Diseases Crispr Casgevy Gene-Editing Therapy CRISPR Gene Editing CRISPR-Based Treatments Muscular Dystrophy Immunotherapy
The groundbreaking gene-editing therapy, Casgevy, offers a potential cure for sickle cell disease and beta thalassemia, but concerns about accessibility and safety remain.